<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 1; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 2; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l6 {padding-left: 0pt;counter-reset: e2 1; }
 #l6> li>*:first-child:before {counter-increment: e2; content: counter(e2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: e2 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: f1 2; }
 #l7> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l8 {padding-left: 0pt;counter-reset: f2 1; }
 #l8> li>*:first-child:before {counter-increment: f2; content: counter(f2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 li {display: block; }
 #l9 {padding-left: 0pt;counter-reset: g1 1; }
 #l9> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: g1 0;  }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"><meta name="viewport" content="width=device-width, initial-scale=1" /></head><body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -75pt;line-height: 115%;text-align: left;">PROTEINS AND PROTEIN FORMULATIONS (MPB 201T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart knowledge and skills necessary for knowing fundamental aspects of proteins and their formulations is a part of drug research and development process. Basic theoretical discussions of the principles of more integrated and coherent use of information for protein formulation and design are provided to help the students to clarify the various biological concepts of protein.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objective</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">At the completion of this course it is expected that students will be able to understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Various methods of purification of proteins</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Peptides in drug development</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Protein identification and characterization</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Protein based formulations</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Sequencing proteins</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                           60 Hrs</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">1. <span class="s2">Protein engineering</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Concepts for protein engineering. Isolation and purification of proteins, Stability and activity based approaches of protein engineering, Chemical and Physical Considerations in Protein and Peptide Stability, Different methods for protein engineering, gene shuffling, and direct evolution.</p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: left;">Peptidomimetics</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Introduction, classification; Conformationally restricted peptides, design, pseudopeptides, peptidomimetics and transition state analogs; Biologically active template; Amino acid replacements; Peptidomimetics and rational drug design; CADD techniques in peptidomimetics; Development of non peptide peptidomimetics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Proteomics</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Protein identification and characterization: Methods/strategies, protein identification, de novo protein characterization, Isotope labelling, N- and C-terminal tags.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;text-align: justify;">2-Dimensional gel electrophoresis</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Methods including immobilized pH gradients (IPGs), resolution, reproducibility and image analysis, future developments</p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: left;">Protein formulation</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Different strategies used in the formulation of DNA and proteins, Analytical and biophysical parameters of proteins and DNA in pre- formulation, Liposomes, Neon-spears, Neon-particulate system, PEGylation, Biological Activity, Biophysical Characterization Techniques, Forced degradation studies of protein.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Methods of protein sequencing</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 83%;text-align: justify;">Various methods of protein sequencing, characterisation, Edman degradation, Tryptic and/or Chymotryptic Peptide Mapping.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l2"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">H. Lodhishet. Al. Molecular Cell Biology, W. H. Freeman and Company</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Protein Purification – Hand Book, Amersham pharmacia biotech</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">EngelbertBuxbaum, Fundamentals of Protein Structure and Function, Springer Science</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Sheldon J. Park, Jennifer R. Cochran, Protein Engineering and Design, CRC press.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Robert K. Skopes. Protein purification, principle and practice, springer link.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">David Whitford, Proteins-Structure and Function, John Wiley &amp; Sons Ltd.</p></li><li data-list-text="7."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">James Swarbrick, Protein Formulation and Delivery Informa Healthcare USA,Inc.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Rodney Pearlman, Y. John Wang Formulation, Characterization, and Stability of Protein Drugs, Kluwer Academic Publishers.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 107pt;text-indent: 0pt;line-height: 113%;text-align: center;">IMMUNOTECHNOLOGY (MPB 202T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart knowledge on production and engineering of antibodies, the application of antigens, the design of (recombinant) vaccines, strategies for immune intervention, etc. The Immunotechnology - based techniques will be used for therapeutics and diagnostics, industries in the production, quality control and quality assurance, and in R&amp;D.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objective</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">After this course, the students will be able to:-</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Understand the techniques like immunodiagnostic tests,</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: left;">  <span class="p">Characterization of lymphocytes, purification of antigens and antibody, etc.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 10pt;text-align: left;">  <span class="p">Access health problems with immunological background;</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Develop approaches for the immune intervention of diseases</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                60 Hrs</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">1.  <span class="s2">Fundamental aspects of immunology</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Introduction, cells and organs of the immune system, cellular basis of Immune response, primary and secondary lymphoid organs, antigen antibody and their structure.</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Types of immune responses, anatomy of immune response. Overview of innate and adaptive Immunity.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Humoral Immunity</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">B – Lymphocytes and their activation. Structure and function of immunoglobulins, idiotypes and anti idiotypic antibodies.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Cell mediated Immunity</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Thymus derived lymphocytes (T cells) – their ontogeny and types, MHC complex, antigen presenting cells (APC), mechanisms of T cell activation, macrophages, dendritic cells, langerhans cells, mechanism of phagocytosis</p><ol id="l3"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 12pt;text-align: left;">Immune Regulation and Tolerance</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Complement activation and types and their biological functions, cytokines and their role in immune response.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;text-align: left;">Hypersensitivity</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Hypersensitivity Types I-IV, Hypersensitivity reactions and treatment</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Autoimmune diseases</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s2" style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Vaccine technology</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Vaccine and their types, conventional vaccines, novel methods for vaccine production, antiidiotype vaccine, DNA vaccine, genetically engineered  vaccine,  iscoms,  synthetic  peptides,  and immunodiagnostics.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stem cell technology</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;text-align: justify;">Stem cell technology and applications to immunology</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Hybridoma Technology</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Hybridoma techniques – fusion methods for myeloma cells and B- Lymphocytes, selection and screening techniques. Production and purification of monoclonal antibodies and their applications in Pharmaceutical industry.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 28pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Immunological Disorder</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Autoimmune disorders and types, pathogenic mechanisms, treatment, experimental models of auto immune diseases, primary and secondary immunodeficiency disorders.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Immunodiagnosis</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Antigen antibody interaction – Precipitation reaction, Agglutination reactions, Principles and applications of ELISA, Radio Immuno Assay, Western blot analysis, immune-electrophoresis, immuno fluorescence, chemiluminescence assay, complement fixation reaction.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l4"><li data-list-text="1."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;">J. Kubey, Immunology – an Introduction.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">S.C. Rastogi, Immunodiagonstics, New Age International.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Ashim Chakravarthy,  Immunology and Immunotechnology, Oxford University Press.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">E. Benjamini, Molecular Immunology.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 14pt;text-indent: 0pt;line-height: 113%;text-align: center;">BIOINFORMATICS AND COMPUTATIONAL BIOTECHNOLOGY (MPB 203T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This paper has been designed to provide the advanced knowledge to the biotechnology students in invaluable areas of advanced bioinformatics which plays a crucial role in determining its future use and applications in medicine, drug discovery and in pharmaceutical industry.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 89%;text-align: left;">Upon completion of this course it is expected that the students will be able to understand,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Use of computers in developing a new drugs</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Biological concepts for bioinformatics</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Proteins and their diversity</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Various gene finding methods</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Searching the biological databases</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Target searching</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Various methods of drug designing</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 14pt;text-indent: 0pt;text-align: center;">THEORY                                60 Hrs</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">1.  <span class="s2">Introduction to Bioinformatics</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Definition and History of Bioinformatics, Internet and Bioinformatics, Introduction to Data Mining, Applications of Data Mining to Bioinformatics,</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Biological Database</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Protein and nucleic acid databases. Structural data bases. Collecting and storing the sequence and Applications of Bioinformatics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l5"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Sequence analysis</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Sequence alignment, pair wise alignment techniques, multiple sequence analysis, multiple sequence alignment; Flexible sequence similarity searching with the FAST3 program package, the use of CLUSTAL W and CLUSTAL X for the multiple sequence alignment. Tools used for sequence analysis.</p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: left;">Protein informatics</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Introduction; Force field methods; Energy, buried and exposed residues, side chains and neighbours; Fixed regions, hydrogen bonds, mapping properties onto surfaces; Fitting monomers, R &amp;</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">S fit of conformers, assigning secondary structures; Sequence alignment-methods, evaluation, scoring; Protein completion, backbone construction and side chain addition; Small peptide methodology, software accessibility, building peptides; Protein displays; Substructure manipulations, annealing.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Protein structure prediction</p><p style="padding-top: 5pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Protein folding and model generation; Secondary structure prediction, analyzing secondary structures; Protein loop searching, loop generating methods, loop analysis; Homology modeling, concepts of homology modeling, potential applications, description, methodology, homologous sequence identification; Align structures, align model sequence; Construction of variable and conserved regions, threading techniques, Topology fingerprint approach for prediction, evaluation of alternate models; Structure prediction on a mystery sequence, structure aided sequence techniques of structure prediction, structural profiles, alignment algorithms, mutation tables, prediction, validation, sequence based methods of structure prediction, prediction using inverse folding, fold prediction; Significance analysis, scoring techniques, sequence- sequence scoring.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Docking</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Docking problems, methods for protein- ligand docking, validation studies and applications; Screening small molecule databases, docking of combinatorial libraries, input data, analyzing docking results.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Diversity of Genomes</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Prokaryotic and Eukaryotic Gene Families. Genome Analysis: Introduction, Gene prediction methods, Gene mapping and applications- Genetic and Physical Mapping, Integrated map, Sequence assembly and gene expression.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Completed Genomes</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Bacterium, Nematode, Plant and Human</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Evolution of Genomes</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Lateral or Horizontal Transfer among Genomes, Transcriptome and Proteome-General Account</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Phylogenetic analysis</p><p style="padding-top: 5pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Evolutionary Change in Nucleotide Sequences, Rates and Patterns of Nucleotide Substitution, Models for Nucleotide Substitution, Construction of Phylogenetic Tree, Genome Annotation technique.</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s2" style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Target searching and Drug Designing</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Target and lead, timeline for drug development, target discovery, target modulators, <span class="s2">In-silico </span>gene expression, microarray, and lead discovery, libraries of ligands, active site analysis, and prediction of drug quality.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l6"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">David W. Mount, Bioinformatics Sequence and Genome Analysis, CBS Publishers and Distributors</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">S. C. Rastogiet. al. Bioinformatics- Concepts Skill and Applications, CBS Publishers and Distributors</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: left;">T. E. Creighton, Protein Structure and Molecular Properties, W.</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">H.Freeman and Company</p></li><li data-list-text="4."><p style="padding-top: 1pt;padding-left: 27pt;text-indent: -15pt;line-height: 85%;text-align: left;">Andreas D. Baxevanis, B. F. Francis Ouellette, Bioinformatics; A Practical Guide to the Analysis of Genes and Proteins, John Wiley &amp; Sons, Inc.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Arthur M. Lesk, Introduction to Bioinformatics, Oxford University Press.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Shui Qing Ye. Bioinformatics: A Practical Approach, Chapman &amp; Hall/CRC.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">David Posada, Bioinformatics for DNA Sequence Analysis, Humana press.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Lesk, A.M. Introduction to Bioinformatics. Oxford University Press.</p></li><li data-list-text="9."><p style="padding-left: 12pt;text-indent: 0pt;line-height: 90%;text-align: left;">Letovsky, S.I. Bioinformatics. Kluwer Academic Publishers. 10.Baldi, P. and Brunak, S. Bioinformatics. The MIT Press.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 54pt;text-indent: 0pt;line-height: 113%;text-align: center;">BIOLOGICAL EVALUATION OF DRUG THERAPY (MPB 204T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: justify;">This paper has been designed to provide the knowledge to the biotechnology students to understand the importance of biological and evaluation of drug therapy of biological medicines.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objective</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">At the completion of this subject it is expected that students will be able to,</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Understand about the general concept of standardization of biological.</span></p><p class="s2" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: left;">  <span class="p">Understand the importance of transgenic animals and knockout animals.</span></p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">Understand the biological medicines in development of various diseases.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 11pt;text-align: left;">  <span class="p">Learn the biological evaluation of drugs </span>in vitro <span class="p">and </span>in vivo</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 14pt;text-indent: 0pt;text-align: center;">THEORY                                60 Hrs</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">1. <span class="s2">Biological Standardization</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">General principles, Scope and limitation of bio-assay, bioassay of some official drugs.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Preclinical drug evaluation</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Preclinical drug evaluation of its biological activity, potency and toxicity-Toxicity test in animals including acute, sub-acute and chronic toxicity, ED50 and LD50 determination, special toxicity test like teratogenecity and mutagenecity.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Guidelines for toxicity studies</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Various guidelines for toxicity studies. Animal experiments assessing safety of packaging materials.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l7"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Pyrogens</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Pyrogens: Sources, Chemistry and properties of bacterial pyrogens and endotoxins, Official pyrogen tests.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Microbiological assay</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Assay of antibiotics and vitamins.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Biological evaluation of drugs</p><p style="padding-top: 5pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Screening and evaluation (including principles of screening, development of models for diseases: <span class="s2">In vivo </span>models / <span class="s2">In vitro </span>models / cell line study).</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s2" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 79%;text-align: left;">Biologic Medicines in Development for various diseases - By Therapeutic Category</p><p class="s2" style="padding-top: 3pt;padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Genetic Disorders</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Eye related Disorders</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Digestive Disorders</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Diabetes/Related Conditions</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Cardiovascular Disease</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Cancer/Related Conditions</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Blood Disorders</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Autoimmune Disorders</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Infectious Diseases</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Neurologic Disorders</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Skin Diseases</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Organe Transplantation</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 113%;text-align: left;">Biologic Medicines in Development for various diseases – by Product Category</p><p class="s2" style="padding-top: 1pt;padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Antisense</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Vaccines</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Recombinant Hormones/Proteins</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Monoclonal Antibodies (mAb)</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Interferons</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Growth Factors</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Gene Therapy</span></p><p class="s2" style="padding-left: 45pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">RNA Interference</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 80%;text-align: left;">Regulatory aspects  : drugs, biologics and medical devices <span class="p">An introduction to the regulations and documents necessary for approval of a medical product.</span></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Regulatory consideration</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Regulatory consideration for pre-clinical testing and clinical testing of drugs, biologics and medical devices.</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">New Drug Applications for Global Pharmaceutical Product Approvals</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Bioavailability</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Objectives and consideration in bio-availability studies of Biopharmaceuticals, Concept of equivalents, Measurements of bio-availability.</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 88%;text-align: justify;">Determination of the rate of absorption, Bioequivalence and its importance, Regulatory aspects of bio-availability and bioequivalence studies for conventional dosage forms and controlled drug delivery systems of Biopharmaceuticals.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 6pt;text-align: left;">Pharmacokinetics</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Pharmacokinetics:- Basic consideration, Pharmacokinetic models, Application of Pharmacokinetics in new drug development of Biopharmaceuticals and designing of dosage forms and Novel drug delivery systems of Biopharmaceuticals.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l8"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Perkins F.T., Hennessen W. Standardization and Control of Biologicals Produced by Recombinant DNA Technology, International Association of Biological Standardization</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: justify;">J.H. Burn., Biological Standardization, Oxford University Press</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: justify;">Drug Discovery and Evaluation in Pharmacology assay: Vogel</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Chow, Shein, Ching, Design and analysis of animal studies in pharmaceutical development,</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Nodine and Siegler, Animal and Clinical pharmacologic Techniques in Drug Evaluation.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Screening methods in pharmacology (vol I &amp; II), R.A. Turner.</p></li></ol></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 141pt;text-indent: -102pt;line-height: 112%;text-align: left;">PHARMACEUTICAL BIOTECHNOLOGY PRACTICAL - II (MPB 205P)</p><ol id="l9"><li data-list-text="1."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Protein identification</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Protein characterization</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Protein biochemistry</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Recombinant DNA Technology</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Protein expression</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Protein formulations</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Database searching</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Sequence analysis methods</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Protein structure prediction</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Gene annotation methods</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Phylogenetic analysis</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Protein, DNA binding studies</p></li><li data-list-text="13."><p style="padding-top: 1pt;padding-left: 27pt;text-indent: -18pt;line-height: 85%;text-align: left;">Preparation of DNA for PCR applications – Isolation, Purity and Quantification</p></li><li data-list-text="14."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 11pt;text-align: left;">Introduction to PCR – working of PCR, Programming.</p></li><li data-list-text="15."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Introduction to RT-PCR – working, programming.</p></li><li data-list-text="16."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Primer design using softwares.</p></li><li data-list-text="17."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Gene DNA amplification by random / specific primers.</p></li><li data-list-text="18."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Southern Hybridization</p></li><li data-list-text="19."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Western Blotting</p></li><li data-list-text="20."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Gene transformation</p></li></ol></body></html>
